Stemline Therapeutics (STML) Soars: Stock Up 39.5% - Tale of the Tape

Comment

Shutterstock photo

Stemline Therapeutics, Inc. ( STML ) was a big mover last session, as its shares rose almost 40% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $19.08 to $21.09.

In the last 30 days, the company did not witness any estimate revision, while the Zacks Consensus Estimate moved higher. Friday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Stemline currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Gentium S.p.A ( GENT ), Emergent BioSolutions, Inc. ( EBS ) and Actelion Ltd . ( ALIOF ). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>


ACTELION LTD (ALIOF): Get Free Report

EMERGENT BIOSOL (EBS): Free Stock Analysis Report

GENTIUM SPA-ADR (GENT): Free Stock Analysis Report

STEMLINE THERAP (STML): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: Investing , Investing Ideas , Stocks
More Headlines for: ALIOF , EBS , GENT , STML


More from Zacks.com

Subscribe






Zacks.com
Contributor:

Zacks.com

Equity Research
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com